|
2025 Journal Article Colorectal cancer in pregnancy: case discussions and real-world data as well as literature review on current knowledgePoulgrain, Suzanne, Gibbons, Ted, O’Leary, Cian, Feng, Sophie, Jain, Vikram and O’Leary, Connor Gerard (2025). Colorectal cancer in pregnancy: case discussions and real-world data as well as literature review on current knowledge. The Oncologist, 30 (7) oyaf097, 1-8. doi: 10.1093/oncolo/oyaf097 |
|
2025 Journal Article CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in IrelandMullally, W. J., Hassan, A., Keegan, N., O'Leary, C., Mcsorley, L., Mahgoub, T., O'Reilly, S., Walshe, J., Kennedy, M. J., Coate, L., O'Connor, M., Keane, M., Kelly, C. M., Duffy, K., Murphy, C. G., Milewski, M., Molloy, S., Egan, K., Murphy, V., Breathnach, O. S., Grogan, L., Hennessy, B. T. and Morris, P. G. (2025). CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in Ireland. Irish Journal of Medical Science, 194 (3), 839-846. doi: 10.1007/s11845-025-03922-7 |
|
2025 Journal Article Rearranged during transfection (RET) lung cancer - update on targeted therapiesMullally, W. J., O'Leary, C. G. and O'Byrne, K. J. (2025). Rearranged during transfection (RET) lung cancer - update on targeted therapies. Lung Cancer, 200 108083, 1-11. doi: 10.1016/j.lungcan.2025.108083 |
|
2024 Journal Article Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancerYaghoubi Naei, Vahid, Ivanova, Ekaterina, Mullally, William, O'Leary, Connor G, Ladwa, Rahul, O'Byrne, Ken, Warkiani, Majid E and Kulasinghe, Arutha (2024). Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer. Clinical and Translational Immunology, 13 (6) e1516, e1516. doi: 10.1002/cti2.1516 |
|
2023 Journal Article Targeted therapies for kirsten rat sarcoma (KRAS) G12C mutant metastatic non-small-cell lung cancersO'Leary, Cian, Murphy, Grace, Yeung, Yong, Tang, Ming, Jain, Vikram and O'Leary, Connor G. (2023). Targeted therapies for kirsten rat sarcoma (KRAS) G12C mutant metastatic non-small-cell lung cancers. Cancers, 15 (23) 5582. doi: 10.3390/cancers15235582 |
|
2023 Journal Article Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoringAhmed, Mostak, Wuethrich, Alain, Constantin, Nicolas, Shanmugasundaram, Karthik Balaji, Mainwaring, Paul, Kulasinghe, Arutha, O’Leary, Connor, O’Byrne, Ken, Sina, Abu Ali Ibn, Carrascosa, Laura G. and Trau, Matt (2023). Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoring. Analytical Chemistry, 95 (22), 8522-8532. doi: 10.1021/acs.analchem.3c00519 |
|
2023 Conference Publication Immune profiling of immunotherapy and adjuvant chemotherapy pretreatment NSCLC tissues by CODEXMonkman, James, Moradi, Afshin, O'Leary, Connor, Wu, Zhenqin, Hamel, Steven, Mason, David, Schneider, Fabian, Mansfield, James Robert, Meyer, Aaron, O'Byrne, Ken and Kulasinghe, Arutha (2023). Immune profiling of immunotherapy and adjuvant chemotherapy pretreatment NSCLC tissues by CODEX. AACR Annual Meeting 2023, Orlando, FL United States, 14-19 April 2023. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2023-4627 |
|
2023 Conference Publication Polo-like kinase-1 is a novel biomarker in resected non-small cell lung cancer treated with adjuvant platinum-based chemotherapyO'Leary, Connor, Monkman, James, Richard, Derek, O'Byrne, Kenneth, Kulasinghe, Arutha and Adams, Mark (2023). Polo-like kinase-1 is a novel biomarker in resected non-small cell lung cancer treated with adjuvant platinum-based chemotherapy. Australian Lung Cancer Conference 2023, Gold Coast, QLD Australia, 15-17 February 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Other Outputs Clinical validation of candidate biomarkers in non-small cell lung cancerO'Leary, Connor Gerard (2023). Clinical validation of candidate biomarkers in non-small cell lung cancer. Master's Thesis, School of Biomedical Sciences, Queensland University of Technology. doi: 10.5204/thesis.eprints.238536 |
|
2022 Journal Article Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancerKapeleris, Joanna, Bark, Juliana Müller, Ranjit, Shanon, Irwin, Darryl, Hartel, Gunter, Warkiani, Majid Ebrahimi, Leo, Paul, O’Leary, Connor, Ladwa, Rahul, O'Byrne, Kenneth, Hughes, Brett G.M. and Punyadeera, Chamindie (2022). Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon, 8 (7) e09971, 1-9. doi: 10.1016/j.heliyon.2022.e09971 |
|
2022 Journal Article Pembrolizumab-induced toxic epidermal necrolysis: case reportChow, Kar Ven Cavan, O’Leary, Connor, Paxton-Hall, Fiona, Lambie, Duncan and O’Byrne, Kenneth (2022). Pembrolizumab-induced toxic epidermal necrolysis: case report. Oxford Medical Case Reports, 2022 (3) omac025, 112-3. doi: 10.1093/omcr/omac025 |
|
2021 Conference Publication Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC PatientsKulasinghe, A., Monkman, J., Dutta, S., O’Leary, C., Ladwa, R. and O'Byrne, K. (2021). Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC Patients. 2021 World Conference on Lung Cancer, Virtual, 8-14 September 2021. New York, United States: Elsevier. doi: 10.1016/j.jtho.2021.08.375 |
|
2021 Journal Article The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, O'Leary, Connor, Monkman, James, Bharti, Vandhana, Irwin, Darryl, Dutta, Sanjay, Richard, Derek J., Hughes, Brett, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). Lung Cancer, 160, 73-77. doi: 10.1016/j.lungcan.2021.08.005 |
|
2021 Conference Publication Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLCMonkman, J., O’Leary, C., Richard, D., O'Byrne, K. and Kulasinghe, A. (2021). Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLC. 2021 World Conference on Lung Cancer, Virtual, 8-14 September 2021. New York, United States: Elsevier. doi: 10.1016/j.jtho.2021.08.605 |
|
2021 Journal Article Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national studyPrior, Lisa, O'Dwyer, Richard, Farooq, Abdul Rehman, Greally, Megan, Ward, Cian, O'Leary, Connor, Aslam, Razia, Darwish, Waseem, Ahmed, Nada, Othman, Elly Che, Watson, Geoffrey, Kelly, Deirdre, Gleeson, Jack, Kiely, Lisa, Hassan, Anees, Walsh, Elaine M., O'Reilly, David, Jones, Alfred, Featherstone, Hannah, Lim, Marvin, Murray, Hazel, Hennessy, Bryan T., Smyth, Lillian M., Leonard, Gregory, Grogan, Liam, Breathnach, Oscar, Calvert, Paula, Horgan, Anne M., Coate, Linda ... Walshe, Janice M. (2021). Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study. Breast Cancer Research and Treatment, 189 (1), 269-283. doi: 10.1007/s10549-021-06263-y |
|
2021 Conference Publication The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O'Leary, Connor, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier. doi: 10.1016/S0169-5002(21)00199-9 |
|
2021 Conference Publication The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, Monkman, James, Dutta, Sanjay, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). 19th Annual British Thoracic Oncology Group Conference 2021, Virtual, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00199-9 |
|
2021 Conference Publication The role of the immune microenvironment in EGFR mutant NSCLCMonkman, James, Kulasinghe, Arutha, O’Leary, Connor, Richard, Derek and O’Byrne, Ken (2021). The role of the immune microenvironment in EGFR mutant NSCLC. 19th Annual British Thoracic Oncology Group Conference, Online, 22-23 April 2021. Shannon, Ireland: Elsevier Ireland. doi: 10.1016/s0169-5002(21)00204-x |
|
2021 Journal Article Identification of proteins deregulated by platinum-based chemotherapy as novel biomarkers and therapeutic targets in non-small cell lung cancerRyan, Sarah-Louise, Dave, Keyur A., Beard, Sam, Gyimesi, Martina, McTaggart, Matthew, Sahin, Katherine B., Molloy, Christopher, Gandhi, Neha S., Boittier, Eric, O'Leary, Connor G., Shah, Esha T., Bolderson, Emma, Baird, Anne-Marie, Richard, Derek J., O'Byrne, Kenneth J. and Adams, Mark N. (2021). Identification of proteins deregulated by platinum-based chemotherapy as novel biomarkers and therapeutic targets in non-small cell lung cancer. Frontiers in Oncology, 11 615967. doi: 10.3389/fonc.2021.615967 |
|
2021 Conference Publication TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)Kulasinghe, A., Monkman, J., Taheri, T., Warkiani, M., O’leary, C., Ladwa, R., Richard, D. and O'Byrne, K. (2021). TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). 2020 North America Conference on Lung Cancer, Virtual, 16-17 October 2020. New York, United States: Elsevier. doi: 10.1016/j.jtho.2020.10.098 |
